Literature DB >> 12904614

Prevalence and predictors of default from tuberculosis treatment in Hong Kong.

M Chan-Yeung1, K Noertjojo, C C Leung, S L Chan, C M Tam.   

Abstract

OBJECTIVE: To determine the prevalence and risk factors of default from tuberculosis treatment in Hong Kong.
DESIGN: Retrospective study.
SETTING: Data were obtained from programme forms completed by physicians in the Hong Kong Government Tuberculosis and Chest Service and from medical records from Hong Kong chest clinics. PATIENTS: In all, 5917 patients registered for antituberculous drug therapy in 1996; medical records of 5757 patients were reviewed. MAIN OUTCOME MEASURES: Patients who defaulted treatment were defined as those who had failed to collect medication for more than 2 consecutive months after the date of the last attendance during the course of treatment. Demographic and clinical characteristics, including history, treatment, and outcome, were compared between defaulters and non-defaulters, both among the whole group and among those with pulmonary disease.
RESULTS: There were 442 (8%) patients who defaulted from treatment. Forty-five percent of those who defaulted did so in the first 2 months of treatment. Key risk factors associated with non-compliance were a history of default, male sex, and a history of concomitant liver disease or lung cancer. Among patients with pulmonary tuberculosis (381 defaulters and 1537 non-defaulters), multiple drug resistance was also associated with default from treatment. Among defaulters with pulmonary disease, 39% were still bacteriologically positive at the time of default.
CONCLUSION: Default from treatment may be partially responsible for the persistent high rates of tuberculosis in Hong Kong in the past decade. Health professionals should ensure that all barriers to treatment be removed and that incentives be used to encourage treatment compliance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12904614

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  7 in total

1.  Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area.

Authors:  M-E Jiménez-Corona; L García-García; K DeRiemer; L Ferreyra-Reyes; M Bobadilla-del-Valle; B Cano-Arellano; S Canizales-Quintero; A Martínez-Gamboa; P M Small; J Sifuentes-Osornio; A Ponce-de-León
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

2.  Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis.

Authors:  M T Gler; L J Podewils; N Munez; M Galipot; M I D Quelapio; T E Tupasi
Journal:  Int J Tuberc Lung Dis       Date:  2012-05-07       Impact factor: 2.373

3.  Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study.

Authors:  Bernard N Muture; Margaret N Keraka; Peter K Kimuu; Ephantus W Kabiru; Victor O Ombeka; Francis Oguya
Journal:  BMC Public Health       Date:  2011-09-09       Impact factor: 3.295

4.  Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study.

Authors:  Alyssa Finlay; Joey Lancaster; Timothy H Holtz; Karin Weyer; Abe Miranda; Martie van der Walt
Journal:  BMC Public Health       Date:  2012-01-20       Impact factor: 3.295

5.  Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study.

Authors:  Satya Bhgath Gorityala; Uday Venkat Mateti; Venkateswarlu Konuru; Srinivas Martha
Journal:  J Pharm Bioallied Sci       Date:  2015 Jul-Sep

6.  Evaluation of Health-Related Quality of Life among Tuberculosis Patients in Two Cities in Yemen.

Authors:  Ammar Ali Saleh Jaber; Amer Hayat Khan; Syed Azhar Syed Sulaiman; Nafees Ahmad; Mohamed Saif Anaam
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

7.  Retrospective assessment of the status and determinants of tuberculosis treatment outcome among patients treated in government hospitals in North Shoa Administrative Zone, Amhara Regional State, Ethiopia.

Authors:  Solomon Hailemeskel; Osman Yimer Mohammed; Abdurahman Mohammed Ahmed
Journal:  Res Rep Trop Med       Date:  2017-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.